Diagnostic and Prognostic Value of Circulating KRAS Mutations in Resectable Pancreatic Ductal Adenocarcinoma

被引:0
|
作者
Hipp, J. [1 ]
Hussung, S. [2 ]
Duyster, J. [2 ]
Fichtner-Feigl, S. [1 ]
Fritsch, R. [2 ]
Wittel, U. A. [1 ]
机构
[1] Univ Freiburg, Med Ctr, Dept Gen & Visceral Surg, Freiburg, Germany
[2] Univ Freiburg, Med Ctr, Dept Oncol, Freiburg, Germany
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1392 / 1392
页数:1
相关论文
共 50 条
  • [1] Diagnostic and prognostic value of KRAS mutations in circulating pancreatic ductal adenocarcinoma tumor DNA
    Yang, Xiaowei
    Xu, Wei
    Tian, Xiuyun
    Wu, Jianhui
    Lv, Ang
    Li, Chengpeng
    Guan, Xiaoya
    Qian, Honggang
    Hao, Chunyi
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 622 - 633
  • [2] Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
    Farzad Khalvati
    Yucheng Zhang
    Sameer Baig
    Edrise M. Lobo-Mueller
    Paul Karanicolas
    Steven Gallinger
    Masoom A. Haider
    Scientific Reports, 9
  • [3] Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
    Khalvati, Farzad
    Zhang, Yucheng
    Baig, Sameer
    Lobo-Mueller, Edrise M.
    Karanicolas, Paul
    Gallinger, Steven
    Haider, Masoom A.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [4] Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
    Kim, Dong Wook
    Ahn, Hyemin
    Kim, Kyung Won
    Lee, Seung Soo
    Kim, Hwa Jung
    Ko, Yousun
    Park, Taeyong
    Lee, Jeongjin
    KOREAN JOURNAL OF RADIOLOGY, 2022, 23 (11) : 1055 - 1066
  • [5] Heterogeneity of KRAS Mutations in Pancreatic Ductal Adenocarcinoma
    Hashimoto, Daisuke
    Arima, Kota
    Yokoyama, Naomi
    Chikamoto, Akira
    Taki, Katsunobu
    Inoue, Risa
    Kaida, Takayoshi
    Higashi, Takaaki
    Nitta, Hidetoshi
    Ohmuraya, Masaki
    Hirota, Masahiko
    Beppu, Toru
    Baba, Hideo
    PANCREAS, 2016, 45 (08) : 1111 - 1114
  • [6] Prognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma
    Zhang, Yucheng
    Lobo-Mueller, Edrise M.
    Karanicolas, Paul
    Gallinger, Steven
    Haider, Masoom A.
    Khalvati, Farzad
    FRONTIERS IN ARTIFICIAL INTELLIGENCE, 2020, 3
  • [7] Allelic ratio of KRAS mutations in pancreatic ductal adenocarcinoma
    Lennerz, Jochen K.
    Stenzinger, Albrecht
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] PATHOGENIC KRAS MUTATIONS PROFILE IN PANCREATIC DUCTAL ADENOCARCINOMA
    Iacob, Razvan
    Dima, Simona
    Sorop, Andrei
    Manea, Ioana
    Ionescu, Victor S.
    Spiridon, Andreea G.
    Stoica, Bianca
    Bunduc, Stefania
    Chiosa, Andrei
    Cazacu, Irina M.
    Croitoru, Vlad M.
    Chelaru, Raluca
    Iacob, Speranta
    Becheanu, Gabriel
    Dumbrava, Mona
    Herlea, Vlad
    Croitoru, Adina E.
    Csiki, Irma Eva
    Ceafalan, Laura C.
    Popescu, Irinel
    Gheorghe, Cristian
    GASTROENTEROLOGY, 2023, 164 (06) : S802 - S803
  • [9] Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker
    Song, Byeong Geun
    Kwon, Wooil
    Kim, Hyemin
    Lee, Eun Mi
    Han, Young Min
    Kim, Hongbeom
    Byun, Yoonhyeong
    Lee, Kyung Bun
    Lee, Kwang Hyuck
    Lee, Kyu Taek
    Lee, Jong Kyun
    Jang, Jin-Young
    Park, Joo Kyung
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [10] Prognostic and predictive value of circulating KRAS mutations in stage IV pancreatic cancer
    Hussung, S.
    Follo, M.
    Michalczyk, S.
    Hajkova, A.
    Fritsch, K.
    Boerries, M.
    von Bubnoff, N.
    Scherer, F.
    Duyster, J.
    Fritsch, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 124 - 125